Lisata Therapeutics, Inc. (LSTA) stock
LSTANasdaqPharmaceutical PreparationsFiscal year ends December 31
$1.21−0.07 (-5.47%)
Close on Nov 13, 2026Market cap $10.90MP/E –Yield –
Lisata Therapeutics enterprise value
Enterprise value is market cap plus debt, minus cash: the value of the whole business to all its investors.
Lisata Therapeutics's enterprise value was $245.81K on Nov 11, 2026, against $3.29M a year earlier. Over the last 5 years it ranged from -$61.21M to $28.05M, with a median of -$12.76M.
Enterprise Value at the end of each year
| Period | Period end | Value | Change |
|---|---|---|---|
| 2026 | Nov 11, 2026 | $245.81K | -84.0% |
| 2025 | Dec 31, 2025 | $1.54M | – |
| 2024 | Dec 31, 2024 | -$5.76M | – |
| 2023 | Dec 29, 2023 | -$29.10M | – |
| 2022 | Dec 30, 2022 | -$47.69M | – |
| 2021 | Dec 31, 2021 | -$46.92M | – |
| 2020 | Dec 31, 2020 | -$10.29M | – |
| 2019 | Dec 31, 2019 | -$824.70K | – |
| 2018 | Dec 31, 2018 | -$5.89M | – |
| 2017 | Dec 29, 2017 | -$23.51M | -243.3% |
| 2016 | Dec 30, 2016 | $16.40M | -67.5% |
| 2015 | Dec 31, 2015 | $50.46M | -56.4% |
| 2014 | Dec 31, 2014 | $115.69M | -9.2% |
| 2013 | Dec 31, 2013 | $127.38M | +36.6% |
| 2012 | Dec 31, 2012 | $93.24M | +37.3% |
| 2011 | Dec 30, 2011 | $67.90M | – |
See a number that looks wrong?